Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Journal of Medicinal Chemistry
|
October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents
J L Wright, B W Caprathe, D M Downing, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects
T A Rugsley, M D Davis, H C Akunne, et al.
Neuropharmacology
|
April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects
H C Akunne, K T Zoski, M D Davis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 11, 2010
Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada
P A Groome, B O'Sullivan, W J Mackillop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
August 20, 2003
Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada
L D Jackson, P A Groome, K Schulze, et al.
Cancer
|
February 17, 2001
The role of computed tomography in the T classification of laryngeal carcinoma
L Barbera, P A Groome, W J Mackillop, et al.
Journal of Clinical Epidemiology
|
February 27, 2001
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?
P A Groome, B O'Sullivan, J C Irish, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 18, 2006
Explaining socioeconomic status effects in laryngeal cancer
P A Groome, K M Schulze, S Keller, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Journal of Medicinal Chemistry
|
October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agents
J L Wright, B W Caprathe, D M Downing, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1995
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects
T A Rugsley, M D Davis, H C Akunne, et al.
Neuropharmacology
|
April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effects
H C Akunne, K T Zoski, M D Davis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 11, 2010
Laryngeal cancer treatment and survival differences across regional cancer centres in Ontario, Canada
P A Groome, B O'Sullivan, W J Mackillop, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
August 20, 2003
Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada
L D Jackson, P A Groome, K Schulze, et al.
Cancer
|
February 17, 2001
The role of computed tomography in the T classification of laryngeal carcinoma
L Barbera, P A Groome, W J Mackillop, et al.
Journal of Clinical Epidemiology
|
February 27, 2001
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles?
P A Groome, B O'Sullivan, J C Irish, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 18, 2006
Explaining socioeconomic status effects in laryngeal cancer
P A Groome, K M Schulze, S Keller, et al.
Page
of 8